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D Isotope administration is possible 4 - 6
weeks after total thyroidectomy or 4 -6
weeks after L-thyroxin treatment withdrawal
D radioiodine therapy should be tollowed by
body radioiodine scan pertormed at 72
hours after the therapeutic dose - to asses
foeuses eoncentrating radioiodine
D After administration of therapeutie
radioiodine dose the patient tor 14 days
should avoid to be in contact with other
persons, especially with children and
pregnant women
Complications after radioiodine C31 I)
treatment
The complications are very rare and usually
without clinical manitestations.
Follow-up after radioiodine C31 I) treatment
Follow-up at intervals 6 - 12 months after
radioiodine treatment should include careful
physical examination, neck ultrasonography,
needle biopsy examination is indicated it a lump
is noted. Serum thyroglobulin and TSH
concentration should be measured. Radioiodine
body sean should be pertormed 6 months after
treatment - after 4 - 6 weeks ot L-thyroxin
treatment withdrawal
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VALlDATION OF CONFORMAL
RADIOTHERAPY TREATMENT PLAN-
NING SYSTEMS USING AN ANTRO-
POMORPHIC PHANTOM AND THERMO-
LUMINESCENCE DOSIMETRY
M.P.R. Waligórski1,2, J. Lesiak\ E. Byrski\
B. Rozwadowska-Bogusz1, R. Barańczyk 1 ,
E. Góra\ P. Bilski2, P. Olko2
(1) Centre ot Oncology,
Garncarska 11, PL-30-115 Kraków, Poland
(2) Institute ot Nuelear Physics,
Radzikowskiego 152, PL-31-342 Kraków, Poland
Within the requirements ot a Quality
Assuranee programme in a radiotherapy
department, the ability ot a treatment planning
system (TPS) to accurately ealeulate dose
distributions under realistic conditions
encountered in radiotherapy (RT) should be
validated. This may be aceomplished by
thermoluminescence (TL) dosimetry in
simulated treatment ot antropomorphic
phantoms. In our radiotherapy department,
several planning systems are used concurrently
in 3D conformal treatment ot larger volumes
(with irregular fields obtained via individual
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shielding or multileat collimation) and ot very
smali volumes (stereotactie technique), by
external megavoltage photon beams. Realistic
3D treatment plans were prepared using
CadPlan, Theraplan and BrainLab TPS tor
treating volumes in an Alderson phantom, which
was prepared for topometry (CT-scanned) and
irradiated in tully simulated conditions of patient
RT. Suitably selected TL detectors (some
custom-produced tor these measurements),
were placed inside and around the treated
volumes in the phantom. For every photon
beam applied (Co-60, 6 MV or 9 MV) the TL
detectors, individually corrected, were calibrated
in a standard solid phantom against ionisation
chamber dosimetry. For irradiation ot larger
volumes, standard MTS-N (LiF:Mg,Ti) detectors
were used. For stereotactic irradiation ot smali
volumes in the head (6 MV) special miniature
thermoluminescent LiF:Mg,Ti and LiF:Mg,Cu,P
were developed. The teehnique ot detector
calibration, preparation ot Alderson phantom tor
simulated RT, detector readout and
interpretation ot the measured versus calculated
values ot dose at measurement points inside the
phantom, will be described.
25.
ASSESSMENT OF THE ACCURACY
OF RADlOTHERAPY BY DIGITAL
SUPERPOSITION OF PORTAL AND
RFERENCE IMAGES
P. Gut\ P. Kukołowicz 2, L. Chmielewski\
A. Dąbrowski 2
1 Institute ot Fundamental Technological Research,
PAS, Warsaw,
2 Holycross Cancer Centre, Kielce
Teleradiotherapy imposes the requirement ot
high accuracy in reterenee to its medical as
well as technical aspects. Close adherence to
the geometrical parameters set up in therapy
planning is vital. The current location ot the
irradiation tield and anatomical structures can be
recorded in the portal image acquired during the
therapy course. Assessment ot the treatment
accuracy consists in registration (overlaying) of
the reference and the portal image to compare
the layout ot anatomical structures and the
irradiation field. Edges of the compared features
are difficult to find in the portal image, which is
inherently of low contrasf. Hence, not all the
edges present in the reference image can be
found in the portal one, and the comparison ot
geometries in these images is difficult and time-
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consuming. There exists a need for a tool that
could support and objectify this process.
At present the accuracy assessment is done
manually by an experienced observer. As a rule,
this tedious procedure is not performed
routinely. The wide Iiterature on image
registration refers to portal images made with
beams generated in accelerators rather than
with the cobalt apparata. In Poland more than a
half of patients are treated with cobalt. There are
numerous references to image registration
methods tailored for finding the fitting and non-
fitting fragments of the compared edges.
The majority of these methods lack generality.
The methodology to be presented is general
and requires little user intervention.
• Features to be matched: edges of selected
anatomical structures, irradiation field and
shields, as seen in scanned images.
• Edge detector: zero~second-derivative with
scale fitted to noise and scale of edges,
separately in portal and reference images.
• Geometrical transformation: affine (2
translations, rotation, 2 scalings - along two
coordinate axes).
• Measure of fitting accuracy: modified
Hausdorff distance measure - robust
method based on voting. Parts of the
contours that do not fit the general tendency
are rejected. This is vital if portal images
made with cobalt apparata are analysed.
• Optimisation method for finding the best
transformation: maximum gradient (chamfer
matching).
• Final fit can be calculated with le least
squares method for only those pixels which
were classified as fitting.
• Speed-ups: hierarchical method (pyramid of
resolutions); in some cases: pre-calculated
virtual transformations.
• Automatic classification of edges as
belonging to anatomic structures, irradiation
field or shields is possible.
• Experiments with enhancing the contrast of
portal images using the optical system
transfer function concept.
The software tool will be presented which
makes it possible to correct the therapeutic
system geometry or the location of the patient.
Fuli control of the physician over the
measurement process will be maintained,
according to the requirement of human decision-
making in the therapeutical process. The
registration (overlaying) of a portal and a
reference image is visualised for verification.
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Manual corrections of the result will be possible
in the final version of the program.
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26.
CHROMOSOMAL DAMAGE AND
SURVIVAL OF KERATINOCYTES
AND FIBROBLASTS AFTER IRRADIA-
TION WITH 200 kV OR 25 kV X-RAYS
D. Slonina, K. Brankovic, A. Panteleeva,
W.Dorr
Centre of Oncology, Krakow, Poland, Medical
Faculty Carl Gustav Carus, Technical University,
Dresden, Germany, Forschungszentrum,
Dresden, Germany, Medical Faculty Carl Gustav
Carus, Technical University, Dresden, Germany
A relative biological effectiveness of 1 is
accepted for soft X-rays (25-30 kV), which are
applied in diagnostic radiology (mammography).
However, it has been shown that soft X-rays can
be more effective in celi killing and chromosomai
damage. The present study was initiated to
define biological effects of low-energy X-rays in
vitro. Experiments were performed with 25 kV X-
rays and 200 kV reference X-rays on neonatal
human keratinocytes (HEKn), and NIH/3T3
mouse fibroblasts. Celi survival was studied with
graded doses in a c1onogenic assay,
chromosomai damage in a micronucleus (MN)
assay. The surviving fraction at 2 Gy for
keratinocytes was 46±5% after 200 kV and
33±11 % after 25 kV X-rays. Linear-quadratic
celi survival analysis yielded
a=0.305±0.033 Gy-1 and
(3 =0.048 ±0.011 Gy-2 for 200 kV and
a=0.399±0.103 Gy-1 and
(3=0.048±0.054 Gy-2 for 25 kV. For 3T3
fibroblasts an SF2 of 53±3% after 200 kV and
61 ±18% after 25 kV was observed. Values of
a=0.24 ± 0.02 Gy-1 and
(3 =0.022 ±0.002 Gy-2 for 200 kV and
a=0.10±0.05 Gy-1 and
(3=0.070±0.010 Gy-2 for 25 kV were
derived. In conclusion, keratinocyte survival was
similar for both radiation qualities. For
fibroblasts, a reduction in survival at higher
doses was observed. Results from MN studies
will be presented.
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